Skip to content

Clinical outcomes of Surgeon-Performed Subcostal Transversus Abdominis Plane Block in Reducing Postoperative Pain and Opioid Use Following Laparoscopic Cholecystectomy

Clinical outcomes of Surgeon-Performed Subcostal Transversus Abdominis Plane Block in Reducing Postoperative Pain and Opioid Use Following Laparoscopic Cholecystectomy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250314002
Enrollment
40
Registered
2025-03-14
Start date
2023-11-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic-guided transversus abdominis plane (TAP) block in postoperative pain management for patients undergoing laparoscopic cholecystectomy due to gallstone disease and related complications, including acute cholecystitis and gallstone-related pancreatitis as a pert of multimodal pain control Gallstone, Laparoscopic cholecystectomy,Acute cholecystitis, Transversus abdominis plane block,Minimally invasive surgery, Multimodal pain control

Interventions

Laparoscopic cholecystectomy conducted under general anesthesia. Before the first incision 5 mL of 0.25 percent bupivacaine is administered via infiltration at the umbilical site to ensure local analg
Experimental Procedure/Surgery
Laparoscopic guided subcostal transversus abdominis plane block

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The study included 1.patients aged 18 to 80 years 2.Diagnosed with cholelithiasis and gallstone-related complications, such as acute cholecystitis, acute cholangitis, gallstone-related pancreatitis, and a history of endoscopic retrograde cholangiopancreatography (ERCP). 3. The patients undergoing laparoscopic cholecystectomy at the Department of Surgery, Faculty of Medicine, Srinakharinwirot University, Thailand, between April 1, 2022, and April 30, 2024.

Exclusion criteria

Exclusion criteria: 1.Patients who underwent conversion to open surgery 2. Patient who had allergies to Bupivacaine

Design outcomes

Primary

MeasureTime frame
Cumulative dose of morphine 24 hours after surgery milligrams

Secondary

MeasureTime frame
Pain score (Visual Analog Scale) 24 hours after surgery Point (0-10 points)

Countries

Thailand

Contacts

Public ContactThawatchai Tullavardhana

Srinakhariwirot University

thawatchait@g.swu.ac.th0879791989

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026